Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panos Lehouritis

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|September 17, 2017
Designer bacteria as intratumoural enzyme biofactoriesPanos Lehouritis, Glenn Hogan, Mark Tangney
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 22, 2013
Bacterial-directed enzyme prodrug therapyPanos Lehouritis, Caroline Springer, Mark Tangney
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 26, 2018
In situ biomolecule production by bacteria; a synthetic biology approach to medicineYensi Flores Bueso, Panos Lehouritis, Mark Tangney
Current Gene Therapy|January 27, 2015
In vivo bacterial imaging without engineering; A novel probe-based strategy facilitated by endogenous nitroreductase enzymesMichael Stanton, Michelle Cronin, Panos Lehouritis, et al.
Plos One|June 30, 2017
Intratumoural production of TNFα by bacteria mediates cancer therapyCarola Murphy, Elizabeth Rettedal, Panos Lehouritis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 15, 2015
Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteriaPanos Lehouritis, Michael Stanton, Florence O McCarthy, et al.
Current Medicinal Chemistry|July 23, 2003
Gene regulation in cancer gene therapy strategiesIan Scanlon, Panos Lehouritis, Ion Niculescu-Duvaz, et al.
Journal of Medicinal Chemistry|April 18, 2003
Self-immolative nitrogen mustards prodrugs cleavable by carboxypeptidase G2 (CPG2) showing large cytotoxicity differentials in GDEPTDan Niculescu-Duvaz, Ion Niculescu-Duvaz, Frank Friedlos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapyFrank Friedlos, Panos Lehouritis, Lesley Ogilvie, et al.
Scientific Reports|September 30, 2015
Local bacteria affect the efficacy of chemotherapeutic drugsPanos Lehouritis, Joanne Cummins, Michael Stanton, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|September 17, 2017
Designer bacteria as intratumoural enzyme biofactoriesPanos Lehouritis, Glenn Hogan, Mark Tangney
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 22, 2013
Bacterial-directed enzyme prodrug therapyPanos Lehouritis, Caroline Springer, Mark Tangney
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 26, 2018
In situ biomolecule production by bacteria; a synthetic biology approach to medicineYensi Flores Bueso, Panos Lehouritis, Mark Tangney
Current Gene Therapy|January 27, 2015
In vivo bacterial imaging without engineering; A novel probe-based strategy facilitated by endogenous nitroreductase enzymesMichael Stanton, Michelle Cronin, Panos Lehouritis, et al.
Plos One|June 30, 2017
Intratumoural production of TNFα by bacteria mediates cancer therapyCarola Murphy, Elizabeth Rettedal, Panos Lehouritis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 15, 2015
Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteriaPanos Lehouritis, Michael Stanton, Florence O McCarthy, et al.
Current Medicinal Chemistry|July 23, 2003
Gene regulation in cancer gene therapy strategiesIan Scanlon, Panos Lehouritis, Ion Niculescu-Duvaz, et al.
Journal of Medicinal Chemistry|April 18, 2003
Self-immolative nitrogen mustards prodrugs cleavable by carboxypeptidase G2 (CPG2) showing large cytotoxicity differentials in GDEPTDan Niculescu-Duvaz, Ion Niculescu-Duvaz, Frank Friedlos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapyFrank Friedlos, Panos Lehouritis, Lesley Ogilvie, et al.
Scientific Reports|September 30, 2015
Local bacteria affect the efficacy of chemotherapeutic drugsPanos Lehouritis, Joanne Cummins, Michael Stanton, et al.
Pageof 1